- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04208438
Non-Invasive Jugular Venous Blood Volume Assessment (BVI)
December 18, 2019 updated by: Mark Favot, MD, Wayne State University
The purpose of this study is to evaluate the ability of the Mespere Blood Volume Index (BVI) device to calculate the blood volume in the jugular veins by comparing the measurements from the device to volumetric measurements obtained with ultrasound.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Integrative Biosciences Center - Clinical Research Service Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Healthy volunteers
Description
Inclusion Criteria:
- 18 years of age or greater
- English-speaking
- No known medical conditions requiring treatment by a physician
Exclusion Criteria:
- Substantial amount of neck hair preventing adhesion of the neck patch of the BVI
- History of congenital heart disease
- History of thoracic, neck or brain surgery
- Inability to lay supine at 30 degrees incline or 60 degrees incline for the duration of the study measurements
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
BVI Cohort
Cohort to have ultrasound and Mespere BVI device applied.
|
Non-Invasive measurement of jugular blood volume using Mespere BVI device
Point-of-Care ultrasound of external and internal jugular veins
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of jugular vein blood volume
Time Frame: One Hour
|
Comparison of measurement of blood volume in jugular vein using BVI and POCUS
|
One Hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of changes in measurement of jugular venous blood volume
Time Frame: One Hour
|
BVI vs POCUS at head of bed angle degrees 0, 30, and 60.
|
One Hour
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 5, 2019
Primary Completion (Actual)
August 9, 2019
Study Completion (Actual)
October 7, 2019
Study Registration Dates
First Submitted
December 18, 2019
First Submitted That Met QC Criteria
December 18, 2019
First Posted (Actual)
December 23, 2019
Study Record Updates
Last Update Posted (Actual)
December 23, 2019
Last Update Submitted That Met QC Criteria
December 18, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- 20201216
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.